Cargando…
Improving the utility and sustainability of novel health technology to improve clinical outcomes for patients: an East Staffordshire experience of screening for atrial fibrillation with the AliveCor KardiaMobile
Autores principales: | Mathew, Savio, Chambers, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal College of General Practitioners
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170609/ https://www.ncbi.nlm.nih.gov/pubmed/33622682 http://dx.doi.org/10.3399/BJGPO.2020.0169 |
Ejemplares similares
-
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results
por: Goldenthal, Isaac L., et al.
Publicado: (2019) -
Effectiveness of a single lead AliveCor electrocardiogram application for the screening of atrial fibrillation: A systematic review
por: Hall, Angela, et al.
Publicado: (2020) -
Comparison of Apple Watch vs KardiaMobile: A Tale of Two Devices
por: Lee, Calvin, et al.
Publicado: (2022) -
Single-lead ECGs (AliveCor) are a feasible, cost-effective and safer alternative to 12-lead ECGs in community diagnosis and monitoring of atrial fibrillation
por: Bray, Jonathan James Hyett, et al.
Publicado: (2021) -
Increasing Early Cardiac Screening in an Inpatient Psychiatric Setting Using the KardiaMobile 6 Lead Device
por: Pierscionek, Tomasz, et al.
Publicado: (2023)